HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Parhofer, K. G. Articles by Schwandt, P. Search for Related Content PubMed PubMed Citation Articles by Parhofer, K. G. Articles by Schwandt, P. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 41, 1596-1603, October 2000
Copyright © 2000 by Lipid Research, Inc.

Original Article

Acute effects of low density lipoprotein apheresis on metabolic parameters of apolipoprotein B

Correspondence to: Klaus G. Parhofer

Apheresis is a treatment option for patients with severe hypercholesterolemia and coronary artery disease. It is unknown whether such therapy changes kinetic parameters of lipoprotein metabolism, such as apolipoprotein B (apoB) secretion rates, conversion rates, and fractional catabolic rates (FCR). We studied the acute effect of apheresis on metabolic parameters of apoB in five patients with drug-resistant hyperlipoproteinemia, using endogenous labeling with D₃-leucine, mass spectrometry, and multicompartmental modeling. Patients were studied prior to and immediately after apheresis therapy. The two tracer studies were modeled simultaneously, taking into account the non-steady-state concentrations of apoB. The low density lipoprotein (LDL)-apoB concentration was 120 ± 32 mg dl^-1 prior to and 52 ± 18 mg dl^-1 immediately after apheresis therapy. The metabolic studies indicate that no change in apoB secretion (13.9 ± 4.9 mg kg^-1 day^-1) is required to fit the tracer and apoB mass data obtained before and after apheresis and that in four of the five patients the LDL-apoB FCR (0.21 ± 0.02 day^-1) was not altered after apheresis. In one subject the LDL-apoB FCR temporarily increased from 0.22 day^-1 to 0.35 day^-1 after apheresis. The conversion rate of very low density lipoprotein (VLDL)-apoB to LDL-apoB is temporarily decreased from 76 to 51% after apheresis and thus less LDL-apoB is produced after apheresis.

We conclude that an acute reduction of LDL-apoB concentration does not affect apoB secretion or LDL-apoB FCR, but that apoB conversion to LDL is temporarily decreased. Thus, in most patients the decreased rate of delivery of neutral lipids or apoB to the liver does not result in an upregulation of LDL receptors or in decreased apoB secretion.—Parhofer, K. G., P. H. R. Barrett, T. Demant, and P. Schwandt. Acute effects of low density lipoprotein apheresis on metabolic parameters of apolipoprotein B. J. Lipid Res. 2000. 41: 1596;–1603.

Supplementary key words: apheresis, lipoprotein metabolism, apoB-100, non-steady-state kinetics, kinetics, compartmental models

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. G. Parhofer and P. H. R. Barrett Thematic review series: Patient-Oriented Research. What we have learned about VLDL and LDL metabolism from human kinetics studies J. Lipid Res., August 1, 2006; 47(8): 1620 - 1630. [Abstract] [Full Text] [PDF]

				H. C. Geiss, S. Bremer, P. H. R. Barrett, C. Otto, and K. G. Parhofer In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy: rebound analysis of LDL subfractions after LDL apheresis J. Lipid Res., August 1, 2004; 45(8): 1459 - 1467. [Abstract] [Full Text] [PDF]